PriOmics: integration of high_throughput proteomic data with complementary omics layers using mixed graphical modeling with group priors
RNA-seq (gene expression) · human · 360 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Diffuse large B-cell lymphomaThis series is part of our curated briefing on it.
- Samples
- 360 samples: 360 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Integration of high-throughput proteomic data and complementary omics layers with PriOmicsGenome research · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE253910_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1067652 and SRA study SRP485254. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 360 sample titles: 360 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8030003 1_DENSER_M_69
- GSM8030004 100_DENSER_F_64
- GSM8030005 101_DENSER_F_67
- GSM8030006 101_RICOVER_60_F_67
- GSM8030007 1013_RICOVER_60_F_65
- GSM8030008 1018_RICOVER_60_F_67
- GSM8030009 102_RICOVER_60_F_76
- GSM8030010 104_DENSER_F_63
- GSM8030011 1058_RICOVER_60_F_64
- GSM8030012 106_DENSER_F_61
- GSM8030013 1060_RICOVER_60_F_71
- GSM8030014 1081_RICOVER_60_M_67
- GSM8030015 111_RICOVER_60_M_68
- GSM8030016 1128_RICOVER_60_F_79
- GSM8030017 114_DENSER_M_65
- GSM8030018 1148_RICOVER_60_M_65
- GSM8030019 116_DENSER_M_67
- GSM8030020 1164_RICOVER_60_M_75
- GSM8030021 1175_RICOVER_60_M_73
- GSM8030022 118_DENSER_F_69
- GSM8030023 119_DENSER_M_65
- GSM8030024 1190_RICOVER_60_M_75
- GSM8030025 12_DENSER_M_70
- GSM8030026 120_RICOVER_60_M_74
- GSM8030027 122_DENSER_F_67
- GSM8030028 123_RICOVER_60_M_71
- GSM8030029 1235_RICOVER_60_F_66
- GSM8030030 124_RICOVER_60_F_70
- GSM8030031 1247_RICOVER_60_F_77
- GSM8030032 1248_RICOVER_60_F_78
- GSM8030033 126_RICOVER_60_F_72
- GSM8030034 126_SMARTER_F_76
- GSM8030035 1269_RICOVER_60_M_74
- GSM8030036 128_SMARTER_M_74
- GSM8030037 1283_RICOVER_60_F_61
- GSM8030038 1287_RICOVER_60_M_75
- GSM8030039 1289_RICOVER_60_M_72
- GSM8030040 13_DENSER_F_79
- GSM8030041 1304_RICOVER_60_F_61
- GSM8030042 131_SMARTER_M_61
+ 320 more — browse all 360 samples with per-sample file links →
- GSE193566 Longitudinal gene expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma 76 samples same disease briefing
- GSE262621 Gene expression profiling of HIV-associated diffuse large B-cell lymphomas from Malawi 70 samples same disease briefing
- GSE277575 Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment 62 samples same disease briefing
- GSE267097 Pre-Treatment peripheral Immune composition can accurately predict CAR-T outcomes in patients with Large B-Cell Lymphoma 49 samples same disease briefing
- GSE231624 (1) Effect of KLHL6 loss on the transcriptome in DLBCL upon NOTCH ligand stimulation. (2) Effect of KLHL6 and NOTCH2 loss on the transcriptome in DLBCL. (3) Effect of DLBCL-associated NOTCH2 mutants on the transcriptome in DLBCL. 48 samples same disease briefing
- GSE277665 DOT1L and EZH2 cooperatively repress PRC2 targets to maintain the GC B cell identity in DLBCL [RNA-seq] 48 samples same disease briefing
- GSE213555 Molecular and pathological characterisation of diffuse large B-cell lymphomas in children with Nijmegen breakage syndrome 41 samples same disease briefing
- GSE224867 RNA-seq analysis of DLBCL cell lines in response to chemotherapy 36 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.